Vincent Medical Holdings Limited (HK:1612) has released an update.
Vincent Medical Holdings Limited reported a solid first half of 2024, with a revenue increase of 5.4% to HK$380.7 million, driven by a notable 50.9% growth in their imaging disposable products segment. The company’s profit before tax rose by 4.6%, and net profit surged by 23.9%, resulting in a higher interim dividend of HK1.6 cents per share. These results underscore Vincent Medical’s robust performance and sustained commitment to R&D, with a new production facility set to begin trial operations by the end of 2025.
For further insights into HK:1612 stock, check out TipRanks’ Stock Analysis page.
